Drug regimen for tb

Most surprisingly, the compound even reversed drug resistance.

Regimen laboral de la pequeña empresa 2017

Tuberculosis bacteria with mutations in a specific gene can withstand isoniazid treatment. But such bacteria die when treated with isoniazid plus the compound, the researchers discovered. We had no idea we would be able to reverse drug resistance. Although, the compound is not ready to be used in people or even be tested in animals, cautions Christina Stallings.

Would pan-tuberculosis treatment regimens be cost-effective?

This study was conducted on bacteria growing in a lab. The researchers are still figuring out whether the compound is safe and how it might be processed by the body. We are also trying to figure out how it prevents biofilm formation so we can develop other drugs that target the pathway.

Cla maigrir wrap

Image: The bacterium Mycobacterium tuberculosis causes turberculosis in humans. The discovery will be useful in the development of medicines capable of targeting specific diseases, according to the scientists behind the study…. Researchers of organic chemistry and biotechnology from the University of Turku are creating new medical technologies in an Ecosystem coordinated by Orion Corporation.

One goal of the…. Close Sidebar. Malin Otmani. Share Tweet Share Pin it.

Mp regimental store edinburgh

Screened 91 molecular compounds Tuberculosis is caused by the bacterium Mycobacterium tuberculosis. Reveresed drug resistance Most surprisingly, the compound even reversed drug resistance. Journal page Archives Contents list. Ciobanu, L. Federici, E.

Guidelines for treatment of drug-susceptible tuberculosis and patient care (2017 update)

Article Article Outline. Access to the text HTML. Access to the PDF text. Recommend this article. Save as favorites. Access to the full text of this article requires a subscription. If you are a subscriber, please sign in 'My Account' at the top right of the screen.

Guillemont bN.

Umeå researchers have found a new strategy for tuberculosis treatment

Koul aV. Auteur correspondant. Outline Masquer le plan. Pharmacocinétique chez la souris. Top of the page - Article Outline.